Box 10
Contains 12 Results:
Savage, Charles. "Variation in Ego Feeling Induced by D-Lysergic Acid Diethylamide (LSD-25)," The Psychoanalytic Review. Vol. 42, No. 1 (reprint), January 1955
Underlining and marginalia throughout.
Savage, Charles and Myron J. Stolaroff. "Clarifying the Confusion Regarding LSD-25," The Journal of Nervous and Mental Disease. Vol. 140, No. 3 (reprint), 1965
Two copies.
Savage, Charles, Mary Alice Hughes, and Robert Mogar. "The Effectiveness of Psychedelic (LSD) Therapy: A Preliminary Report," The British Journal of Social Psychiatry. Vol. 2, No. 1 (reprint), 1967
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Savage, Charles. "Psychedelic Therapy," Research in Psychotherapy. Vol. 3 (reprint), 1968
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Savage, Charles, Willis Harman, and James Fadiman. "Questionnaire Study of the Psychedelic Experience, Research Report No. 1," International Foundation for Advanced Study (photocopy), November 1, 1962
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Savage, Charles (et al). "The Effects of Psychedelic (LSD) Therapy on Values, Personality, and Behavior," International Journal of Neuropsychiatry. Vol. 2, No. 3 (reprint), 1966
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Savage, Charles (et al). "Current Status of Psychedelic Research," Prepared for the American Orthopsychiatric Association Meetings (photocopy), March 20 - 23, 1967
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Savage, Charles (et al). "Therapeutic Applications of LSD," Prepared for the Third Annual Conference of Friends of Psychiatric Research, Inc (photocopy), March 30, 1967
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Savage, Charles. "Research with Psychedelic Drugs," Psychedelic Drugs (reprint), 1969
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Savage, Charles (et al). "Psychotherapeutic Usages of LSD and Psilocybin." (typed manuscript), undated
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Savage, Charles (et al). "Process and Outcome Variables in Psychedelic (LSD) Therapy." (preprint), undated
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.
Savage, Charles, O. Lee McCabe, and Albert Kurland. "LSD Therapy of Heroin Addicts: A Controlled Study." (photocopy of typed manuscript), undated
Includes published and unpublished preprints, reprints, abstracts, and drafts of articles on the use of psychotropic substances as a therapeutic agent. It also includes book chapters, letters to the editor, and conference presentations.